Healthcare PEDRA™ Technology Receives FDA Breakthrough Device Designation for its PEDRA™ Xauron™ Real-Time Tissue Perfusion System 25 January 2021 – Singapore PEDRA™ Technology, a privately-held company, announced today that the U.S Food…Natalie GoodridgeJanuary 25, 2021
Healthcare PEDRA™ Technology, Inc. Secures $4.7M Series A Funding for Perfusion Monitoring Technology 22 September 2020 – Singapore PEDRA™ Technology, a Singapore-based developer of innovative deep-tissue perfusion monitors, today…Natalie GoodridgeSeptember 22, 2020
